BONE TURNOVER IN SICKLE CELL DISEASE
BONE TURNOVER IN SICKLE CELL DISEASE
批准号:
7605010
负责人:
John David Roberts
金额:
$0.56万
依托单位国家:
美国
项目类别:
财政年份:
2006
资助国家:
美国
项目状态:
已结题
起止时间:
2006-12-20 至 2007-11-30
关键词:
Alkaline PhosphataseBone PainComputer Retrieval of Information on Scientific Projects DatabaseFundingGrantInstitutionMeasuresN-telopeptidePlayProtocols documentationResearchResearch PersonnelResourcesRoleSerumSickle Cell AnemiaSourceUnited States National Institutes of Healthbonebone metabolismbone turnoversickle cell crisis
中文摘要
点击翻译按钮获取中文摘要
英文摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
It is proposed that an increase in bone turnover may play a role in bone pain and developmemt of sickle cell crisis. Therefore this protocol will measure bone metabolism via quantification of serum bone specific alkaline phosphatase and N-telopeptide.
The aim is to investigate whether increased bone turnover is temporally related to sickle cell crisis.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CLINICAL TRIAL: COMBINED TREATMENT WITH BORTEZOMIB & DACARBAZINE
-
批准号:8166535
-
项目类别:
-
资助金额:$2.24万
-
财政年份:2009
-
负责人:John David Roberts
-
依托单位:
CLINICAL TRIAL: PILOT/PHASE 1 STUDY OF ZOLEDRONIC ACID (ZOMETA ) IN SICKLE CELL
-
批准号:7950882
-
项目类别:
-
资助金额:$0.09万
-
财政年份:2008
-
负责人:John David Roberts
-
依托单位:
Clinical Protocol and Data Management
-
批准号:7698841
-
项目类别:
-
资助金额:$2.1万
-
财政年份:2008
-
负责人:John David Roberts
-
依托单位:
CLINICAL TRIAL: COMBINED TREATMENT WITH BORTEZOMIB & DACARBAZINE
-
批准号:7950860
-
项目类别:
-
资助金额:$3.22万
-
财政年份:2008
-
负责人:John David Roberts
-
依托单位:
CLINICAL TRIAL: NCI 6858: A PHASE 1 STUDY OF SUBEROYLANILIDE HYDROXAMIC ACID (S
-
批准号:7950875
-
项目类别:
-
资助金额:$2.43万
-
财政年份:2008
-
负责人:John David Roberts
-
依托单位:
CLINICAL TRIAL: A PHASE 2 STUDY OF AZD6244 IN ADVANCED OR METASTATIC HEPATOCELLU
-
批准号:7950892
-
项目类别:
-
资助金额:$1.4万
-
财政年份:2008
-
负责人:John David Roberts
-
依托单位:
CLINICAL TRIAL: NCI 6858: A PHASE 1 STUDY OF SUBEROYLANILIDE HYDROXAMIC ACID (S
-
批准号:7717049
-
项目类别:
-
资助金额:$0.91万
-
财政年份:2007
-
负责人:John David Roberts
-
依托单位:
CLINICAL TRIAL: COMBINED TREATMENT WITH BORTEZOMIB & DACARBAZINE
-
批准号:7717028
-
项目类别:
-
资助金额:$0.38万
-
财政年份:2007
-
负责人:John David Roberts
-
依托单位:
COMBINED TREATMENT WITH BORTEZOMIB & DACARBAZINE
-
批准号:7605017
-
项目类别:
-
资助金额:$1.47万
-
财政年份:2006
-
负责人:John David Roberts
-
依托单位:
NCI 6858: A PHASE 1 STUDY OF SUBEROYLANILIDE HYDROXAMIC ACID (SAHA) IN COMBI
-
批准号:7605042
-
项目类别:
-
资助金额:$1.9万
-
财政年份:2006
-
负责人:John David Roberts
-
依托单位:
COMBINED TREATMENT WITH BORTEZOMIB & DACARBAZINE
-
批准号:7375157
-
项目类别:
-
资助金额:$3.29万
-
财政年份:2005
-
负责人:John David Roberts
-
依托单位:
BONE TURNOVER IN SICKLE CELL DISEASE
-
批准号:7375148
-
项目类别:
-
资助金额:$0.06万
-
财政年份:2005
-
负责人:John David Roberts
-
依托单位:
COMBINED TREATMENT WITH BORTEZOMIB & DACARBAZINE
-
批准号:7201520
-
项目类别:
-
资助金额:$0.04万
-
财政年份:2004
-
负责人:John David Roberts
-
依托单位:
Modulation of the Bio. Response to IL-2 with Bryostatin
-
批准号:7040921
-
项目类别:
-
资助金额:$4.33万
-
财政年份:2003
-
负责人:John David Roberts
-
依托单位:
CORE--CLINICAL PROTOCOL AND DATA MANAGEMENT
-
批准号:6592801
-
项目类别:
-
资助金额:$4.12万
-
财政年份:2002
-
负责人:John David Roberts
-
依托单位:
PHASE 1 TRIAL OF BRYOSTATIN AND INTERLEUKIN-2
-
批准号:6087104
-
项目类别:
-
资助金额:$14.18万
-
财政年份:2000
-
负责人:John David Roberts
-
依托单位:
VCU MINORITY-BASED CCOP
-
批准号:6375883
-
项目类别:
-
资助金额:$45.93万
-
财政年份:2000
-
负责人:John David Roberts
-
依托单位:
VCU MINORITY-BASED CCOP
-
批准号:6754374
-
项目类别:
-
资助金额:$46.31万
-
财政年份:2000
-
负责人:John David Roberts
-
依托单位:
VCU MINORITY-BASED CCOP
-
批准号:6633035
-
项目类别:
-
资助金额:$42.93万
-
财政年份:2000
-
负责人:John David Roberts
-
依托单位:
VCU MINORITY-BASED CCOP
-
批准号:6512687
-
项目类别:
-
资助金额:$43.84万
-
财政年份:2000
-
负责人:John David Roberts
-
依托单位:
海外基金